Biotech · Public company · Wilmette, IL, US

Monopar Therapeutics

Ticker MNPR · SEC CIK 0001645469

Track this companyFree. Adds Monopar Therapeutics to your Dealase workspace and tells you when its record changes.

Clinical trials40 recruiting or active

Pipeline programs4From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline4

Clonidine HCl Mucoadhesive Buccal TabletPhase 3 · Chemoradiotherapy-Induced Severe Oral MucositisClinicalTrials.gov · fetched Nov 12, 2026
CamsirubicinPhase 1 · Advanced Soft-tissue SarcomaClinicalTrials.gov · fetched Nov 12, 2026
MNPR-101-DFO*-89ZrCancerClinicalTrials.gov · fetched Nov 12, 2026
MNPR-101-PCTA-177LuCancerClinicalTrials.gov · fetched Nov 12, 2026

Camsirubicin + Pegfilgrastim to Determine MTD in ASTSPHASE1 · TERMINATED · started Sep 22, 2021ClinicalTrials.gov NCT05043649 · fetched Nov 12, 2026
Clonidine HCl MBT vs. Placebo to Prevent Chemoradiotherapy-Induced Severe Oral Mucositis in Oropharyngeal Cancer.PHASE2_PHASE3 · TERMINATED · started Feb 11, 2021ClinicalTrials.gov NCT04648020 · fetched Nov 12, 2026
MNPR-101-DFO*-89Zr Expanded Access Program (EAP) for Patients With Solid Tumor CancerTEMPORARILY_NOT_AVAILABLEClinicalTrials.gov NCT06980506 · fetched Nov 12, 2026
MNPR-101-PCTA-177Lu Expanded Access Program (EAP) for Patients With Solid Tumor CancerTEMPORARILY_NOT_AVAILABLEClinicalTrials.gov NCT06980519 · fetched Nov 12, 2026